Abstract

Transforming growth factor (TGF)-β is a crucial enforcer of immune homeostasis and tolerance, inhibiting the expansion and function of many components of the immune system. Perturbations in TGF-β signaling underlie inflammatory diseases and promote tumor emergence. TGF-β is also central to immune suppression within the tumor microenvironment, and recent studies have revealed roles in tumor immune evasion and poor responses to cancer immunotherapy. Here, we present an overview of the complex biology of the TGF-β family and its context-dependent nature. Then, focusing on cancer, we discuss the roles of TGF-β signaling in distinct immune cell types and how this knowledge is being leveraged to unleash the immune system against the tumor.

Keywords

BiologyImmunityCancerTransforming growth factorCancer researchImmunologyImmune systemCell biologyGenetics

MeSH Terms

Adaptive ImmunityAnimalsDendritic CellsDisease ProgressionEpithelial-Mesenchymal TransitionFibroblastsHumansImmunityInnateInflammationMacrophagesMiceKnockoutNeoplasmsNeutrophilsReceptorsTransforming Growth Factor betaSignal TransductionT-Lymphocyte SubsetsTransforming Growth Factor betaTumor EscapeTumor Microenvironment

Affiliated Institutions

Related Publications

TGF-β SIGNAL TRANSDUCTION

The transforming growth factor β (TGF-β) family of growth factors control the development and homeostasis of most tissues in metazoan organisms. Work over the past few years has...

1998 Annual Review of Biochemistry 7550 citations

Publication Info

Year
2019
Type
review
Volume
50
Issue
4
Pages
924-940
Citations
2114
Access
Closed

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

2114
OpenAlex
37
Influential
1916
CrossRef

Cite This

Eduard Batlle, Joan Massagué (2019). Transforming Growth Factor-β Signaling in Immunity and Cancer. Immunity , 50 (4) , 924-940. https://doi.org/10.1016/j.immuni.2019.03.024

Identifiers

DOI
10.1016/j.immuni.2019.03.024
PMID
30995507
PMCID
PMC7507121

Data Quality

Data completeness: 90%